Outcome measure tag sponsored by:
Outcome measure
-
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety. | Research with
onderzoekmetmensen.nl | | Article Details | Related Articles